MAPK1 and malignant peripheral nerve sheath tumor: We further compared the changes in the ADCY1 and p-ERK levels in SUZ12-positive and SUZ12-negative MPNST patients, and the results were consistent with the hypothesis that SUZ12 loss may affect ERK phosphorylation through ADCY1.